Berveiller, Paul http://orcid.org/0000-0002-7814-6945
Mir, Olivier
Degrelle, Séverine A.
Tsatsaris, Vassilis
Selleret, Lise
Guibourdenche, Jean
Evain-Brion, Danièle
Fournier, Thierry
Gil, Sophie
Funding for this research was provided by:
INSERM poste d'accueil
Article History
Received: 13 May 2018
Accepted: 2 October 2018
First Online: 26 October 2018
Compliance with ethical standards
:
: Dr. Berveiller declares that he has no conflict of interest.Dr. Mir has acted as consultant for Astra-Zeeneca, Amgen, Bayer Healthcare, Blueprint Medicines, Bristol-Myers Squibb, Eli-Lilly, Incyte, Ipsen, Lundbeck, Novartis, Pfizer, PharmaMar, Roche, Servier and Vifor Pharma.Dr. Degrelle declares that she has no conflict of interest.Pr. Tsatsaris declares that he has no conflict of interest.Dr. Selleret declares that she has no conflict of interest.Pr. Guibourdenche declares that he has no conflict of interest.Dr. Evain-Brion declares that she has no conflict of interest.Dr. Fournier declares that he has no conflict of interest.Pr. Gil declares that she has no conflict of interest.
: All procedures performed in studies involving our patients were in accordance with the ethical standards of the Local Ethic Committee (CPP, Paris Cochin, N°18–05, France) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in our study.